ID
12962
Description
Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193037
Link
https://clinicaltrials.gov/show/NCT00193037
Keywords
Versions (1)
- 1/7/16 1/7/16 -
Uploaded on
January 7, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00193037
Eligibility Breast Cancer NCT00193037
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
peripheral neuropathy
Data type
boolean
Alias
- UMLS CUI [1]
- C0031117
Description
heart disease
Data type
boolean
Alias
- UMLS CUI [1]
- C0018799
Description
meningeal metastases
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0027627
- UMLS CUI [1,2]
- C0025284
Description
chemotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0392920
Description
measurable disease
Data type
boolean
Alias
- UMLS CUI [1]
- C1513041
Description
herceptin
Data type
boolean
Alias
- UMLS CUI [1]
- C0338204
Description
pregnancy, lactation
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
additional inclusion/exclusion criteria
Data type
boolean
Similar models
Eligibility Breast Cancer NCT00193037
- StudyEvent: Eligibility
C0027627 (UMLS CUI [1,2])
C0005953 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0025284 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])